Suppression of TNF‐α production in human mononuclear cells by an adenosine kinase inhibitor
暂无分享,去创建一个
G. Hartmann | G. Firestein | D. Boyle | S. Endres | A. Eigler | S. Erhardt | V. Matschke
[1] G. Hartmann,et al. Adenosine kinase inhibitor GP515 improves experimental colitis in mice. , 2000, The Journal of pharmacology and experimental therapeutics.
[2] G. Hartmann,et al. Spontaneous and cationic lipid-mediated uptake of antisense oligonucleotides in human monocytes and lymphocytes. , 1998, The Journal of pharmacology and experimental therapeutics.
[3] S. Endres,et al. Anti‐inflammatory activities of cAMP‐elevating agents: enhancement of IL‐10 synthesis and concurrent suppression of TNF production , 1998, Journal of leukocyte biology.
[4] G. Hartmann,et al. Taming TNF: strategies to restrain this proinflammatory cytokine. , 1997, Immunology today.
[5] D. Boyle,et al. Adenosine inhibits neutrophil degranulation in activated human whole blood: involvement of adenosine A2 and A3 receptors. , 1997, Journal of immunology.
[6] T. Greten,et al. Endogenous Adenosine Curtails Lipopolysaccharide‐Stimulated Tumour Necrosis Factor Synthesis , 1997, Scandinavian journal of immunology.
[7] D. Lalloo,et al. Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha. , 1996, The New England journal of medicine.
[8] O. Moine,et al. Adenosine enhances IL-10 secretion by human monocytes. , 1996, Journal of immunology.
[9] G. Firestein,et al. Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors. , 1996, Journal of immunology.
[10] W. Dostmann. (R P)‐cAMPS inhibits the cAMP‐dependent protein kinase by blocking the cAMP‐induced conformational transition , 1995, FEBS letters.
[11] P. Barnes,et al. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase. , 1995, Molecular pharmacology.
[12] M. Thiel,et al. Acting via A2 receptors, adenosine inhibits the production of tumor necrosis factor-alpha of endotoxin-stimulated human polymorphonuclear leukocytes. , 1995, The Journal of laboratory and clinical medicine.
[13] G. Firestein,et al. The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine. , 1995, Arthritis and rheumatism.
[14] S. Endres,et al. Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids , 1995, European journal of immunology.
[15] M. Erion,et al. Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor. The role of selectins. , 1995, Journal of immunology.
[16] W. Buurman,et al. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. , 1994, Journal of immunology.
[17] J. Woody,et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis , 1994, The Lancet.
[18] J. Woody,et al. Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis , 1994, The Lancet.
[19] G. Firestein,et al. Protective effect of an adenosine kinase inhibitor in septic shock. , 1994, Journal of immunology.
[20] J. Lemasters,et al. Suppression of lipopolysaccharide‐stimulated release of tumor necrosis factor by adenosine: Evidence for A2 receptors on rat kupffer cells , 1994, Hepatology.
[21] P. Vandenabeele,et al. Interleukin‐10 controls interferon‐γ and tumor necrosis factor production during experimental endotoxemia , 1994, European journal of immunology.
[22] M. Goldman,et al. Interleukin‐10 inhibits B7 and intercellular adhesion molecule‐1 expression on human monocytes , 1994, European journal of immunology.
[23] S. Endres,et al. Prostacyclin analogs suppress the synthesis of tumor necrosis factor-alpha in LPS-stimulated human peripheral blood mononuclear cells. , 1993, Immunopharmacology.
[24] D. Morrison,et al. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge. , 1993, Journal of immunology.
[25] S. Endres,et al. The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells. , 1993, International journal of immunopharmacology.
[26] S. Abramson,et al. Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. , 1992, Journal of immunology.
[27] Y. Vodovotz,et al. Macrophage deactivation by interleukin 10 , 1991, The Journal of experimental medicine.
[28] C G Figdor,et al. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.
[29] S. Shurtleff,et al. Regulation of tumor necrosis factor expression in a macrophage-like cell line by lipopolysaccharide and cyclic AMP. , 1989, Cellular immunology.
[30] J. Schrader,et al. Turnover of adenosine in plasma of human and dog blood. , 1989, The American journal of physiology.
[31] C. Tannenbaum,et al. Lipopolysaccharide-induced gene expression in murine peritoneal macrophages is selectively suppressed by agents that elevate intracellular cAMP. , 1989, Journal of immunology.
[32] J. Meer,et al. Measurement of immunoreactive interleukin-1 beta from human mononuclear cells: optimization of recovery, intrasubject consistency, and comparison with interleukin-1 alpha and tumor necrosis factor. , 1988, Clinical immunology and immunopathology.
[33] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[34] A. Bøyum,et al. Isolation of mononuclear cells and granulocytes from human blood. , 1968 .
[35] A. Böyum,et al. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. , 1968, Scandinavian journal of clinical and laboratory investigation. Supplementum.